|
HepC Newsletter
|
Dema-@aol.com
|
Jul 01, 2009 21:37 PDT
|
NATAP http://natap.org/
_______________________________________________
Future HCV Burden
_Liver Cancer Rates Triple: Hepatocellular Carcinoma Incidence, Mortality,
and Survival Trends in the United States From 1975 to 2005 _
(http://www.natap.org/2009/HCV/060309_01.htm) - (06/03/09)
_Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic
of Liver Disease MAY 2009_ (http://www.natap.org/2009/HCV/051809_01.htm) -
(05/18/09)
EASL: _EASL Analysis, New Oral HCV Drugs What's Expected _
(http://www.natap.org/2009/EASL/EASL_85.htm) - (05/14/09)
_Hepatitis Advocacy Update: Congressional Black Caucus Requests Federal
Funding, for African-Americans The HCV Prevalence Rate is Double Compared To
All Others in the USA; Congressmen Request Funding Support; Pres Obama
Recognizes hepatitis with a Statement _
(http://www.natap.org/2009/HCV/052809_01.htm) - (05/28/09)
_Estimating future hepatitis C morbidity, mortality, and costs in ..._
(http://www.natap.org/2003/Jan/012103_2.htm)
Estimating future hepatitis C morbidity, mortality, and costs in the
United States. This study estimated future morbidity, mortality, and costs
resulting ...
www.natap.org/2003/Jan/012103_2.htm
Our projections for hepatitis C likely underestimated the long-term costs
be-cause they did not include future expenses related to periodic liver
biopsy, screening for hepatocellular carcinoma, and treatment costs. . This
study estimated future morbidity, mortality, and costs resulting from
hepatitis C virus (HCV). We used a computer cohort simulation of the natural
history of HCV in the US population.
From the year 2010 through 2019, our model projected 165,900 deaths from
chronic liver disease, 27,200 deaths from hepatocellular carcinoma, and
$10.7 billion in direct medical expenditures for HCV. During this period, HCV
may lead to 720,700 years of decompensated cirrhosis and hepatocellular
carcinoma and to the loss of 1.83 million years of life in those younger than 65
at a societal cost of $21.3 and $54.2 billion, respectively
*****************
New HCV Drugs, Special Population (Coinfectio) Access: 4th International
Workshop on Hepatitis C, Resistance and New Compounds 25-26 June 2009,
Boston, MA U
_http://www.natap.org/2009/HCVresist/HCVresist_02.htm_
(http://www.natap.org/2009/HCVresist/HCVresist_02.htm)
FDA Loosens Up HCV Drug Development - HCV Boston Meeting June 27, 2009
_http://www.natap.org/2009/HCVresist/HCVresist_01.htm_
(http://www.natap.org/2009/HCVresist/HCVresist_01.htm)
Liver Cancer Rates Triple: Hepatocellular Carcinoma Incidence, Mortality,
and Survival Trends in the United States From 1975 to 2005
_http://www.natap.org/2009/HCV/060309_01.htm_
(http://www.natap.org/2009/HCV/060309_01.htm)
Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic
of Liver Disease MAY 2009
_http://www.natap.org/2009/HCV/051809_01.htm_
(http://www.natap.org/2009/HCV/051809_01.htm)
Hepatitis Advocacy Update: Congressional Black Caucus Requests Federal
Funding, for African-Americans The HCV Prevalence Rate is Double Compared To
All Others in the USA; Congressmen Request Funding Support; Pres Obama
Recognizes hepatitis with a Statement
_http://www.natap.org/2009/HCV/052809_01.htm_
(http://www.natap.org/2009/HCV/052809_01.htm)
FDA Loosens Up HCV Drug Development
HCV Boston Meeting June 27, 2009
_http://www.natap.org/2009/HCVresist/HCVresist_01.htm_
(http://www.natap.org/2009/HCVresist/HCVresist_01.htm)
**************Dell Summer Savings: Cool Deals on Popular Laptops – Shop
Now!
(http://pr.atwola.com/promoclk/100126575x1222696924x1201468348/aol?redir=http:%2F%2Faltfarm.mediaplex.com%2Fad%2Fck%2F12309%2D81939%2D1629%2D1)
|
|
 |
|
